Gentaur Donanemab – Anti-APP Antibody
Targets amyloid precursor protein (APP), used in Alzheimer’s disease research, amyloid clearance, and neurodegeneration assays.
Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.